Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Pathology and AI
AI-powered endoscope doubles detection of high-risk esophageal lesions
By
Nick Paul Taylor
Deep learning has doubled the detection of high-risk lesions during routine endoscopies in a clinical trial of more than 3,000 patients in China.
April 17, 2024
Researchers design AI model to generate new antibiotics
By
LabPulse.com staff writers
Researchers have devised an artificial intelligence (AI) model to develop potential new antibiotics which chemists can synthesize in the lab.
April 9, 2024
Ibex presents new study data for AI-powered cancer diagnostics platform
By
Matt Limb
Ibex Medical Analytics is hailing positive data from studies with U.S. partners on the impact of its artificial intelligence (AI)-powered cancer diagnostic platform Galen.
March 26, 2024
Protein design firm Profluent raises $35M in funding
By
LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
QDx Pathology Services to adopt Proscia's digital pathology software
By
LabPulse.com staff writers
QDx Pathology Services, an independent anatomical, molecular, and clinical pathology laboratory, is working with digital pathology software firm Proscia to deploy Proscia's software in its Edison, NJ, laboratory.
March 20, 2024
AI foundation models set new benchmarks in computational pathology
By
Nick Paul Taylor
Mass General Brigham researchers have published a pair of papers on artificial intelligence (AI) systems that could improve tasks that include the analysis of pathology images and identification of rare diseases.
March 20, 2024
Machine-learning model predicts lung and liver cancer through genome sequence changes
By
LabPulse.com staff writers
Researchers have developed a machine-learning approach that may potentially predict early-stage lung or liver cancer by detecting repetitive sequences in the genome.
March 15, 2024
Zephyr AI closes $111M series A funding round
By
LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
Predictive AI model might aid early-stage NSCLC planning
By
Liz Carey
The deep-learning AI model identified features that were not readily discernable to a trained pathologist.
March 12, 2024
Study: AI assists discovery of prostate cancer subtypes
By
Matt Limb
Prostate tumors have been found to evolve along multiple pathways, leading to two distinct disease types with “pivotal” implications for diagnosis and treatment, say scientists.
March 8, 2024
Ibex, PathPresenter ink partnership
By
LabPulse.com staff writers
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.
March 6, 2024
CAP releases updated guideline for validation of IHC assays
By
LabPulse.com staff writers
The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical assays to provide increased accuracy and consistency in laboratory practices.
February 26, 2024
Page 1 of 176
Next Page
